The FDA issued a nationwide Class II recall of levothyroxine, a common thyroid medication, due to concerns over potency.

As adoption in prediction markets continues to grow, I believe traditional markets and these novel markets will converge.

Initiate coverage of Immunovant (IMVT) with a BUY and $50 price target based on IMVT-1402’s best-in-class IgG reduction and ...

What do you mean by olodo uprising? Who are you referring to exactly? Why are you trying to discredit content creators who ...

The company that brought institutional-grade order flow analysis capabilities to the browser now brings it to event contracts - a first for the asset class. Free to start; U.S. and international ...

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and ...

Even having to play "catch-up", the new Auburn head coach is beating out some of the best head coaches on the recruiting trail. Alex Golesh has begun his tenure as the head coach of the Auburn Tigers ...

Eggs are one of several diet staples that lately have been top-of-mind, thanks to a recall on "multiple brand names" that the ...

Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine ...

For every paper leak that makes headlines, there are seven deeper failures of NEET that decide who gets to become a doctor ...

The Food and Drug Administration has recalled a commonly prescribed thyroid medication. The recall involves levothyroxine ...

Here’s what to know.